tiprankstipranks
Trending News
More News >
Towa Pharmaceutical Co Ltd (TWAPF)
OTHER OTC:TWAPF
US Market

Towa Pharmaceutical Co (TWAPF) Financial Statements

Compare
1 Followers

Towa Pharmaceutical Co Financial Overview

Towa Pharmaceutical Co's market cap is currently $1.01B. The company's EPS TTM is $0.60121885; its P/E ratio is 10.01; and it has a dividend yield of 0.01%. Towa Pharmaceutical Co is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $0.43. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 259.59B¥ 227.93B¥ 208.86B¥ 165.62B¥ 154.90B
Gross Profit¥ 94.73B¥ 81.38B¥ 72.71B¥ 70.19B¥ 65.45B
Operating Income¥ 23.24B¥ 17.65B¥ 5.51B¥ 19.20B¥ 19.92B
EBITDA¥ 48.05B¥ 35.54B¥ 24.92B¥ 29.49B¥ 30.35B
Net Income¥ 18.99B¥ 16.17B¥ 2.20B¥ 15.91B¥ 13.96B
Balance Sheet
Cash & Short-Term Investments¥ 45.47B¥ 29.65B¥ 24.26B¥ 32.83B¥ 22.91B
Total Assets¥ 470.82B¥ 430.65B¥ 371.35B¥ 329.94B¥ 245.67B
Total Debt¥ 230.98B¥ 202.36B¥ 173.06B¥ 144.13B¥ 84.77B
Net Debt¥ 185.51B¥ 172.71B¥ 148.81B¥ 111.30B¥ 61.85B
Total Liabilities¥ 299.19B¥ 274.76B¥ 234.45B¥ 197.77B¥ 129.07B
Stockholders' Equity¥ 171.63B¥ 155.89B¥ 136.89B¥ 132.17B¥ 116.60B
Cash Flow
Free Cash Flow¥ -5.33B¥ -31.11B¥ -27.93B¥ 8.55B¥ 2.13B
Operating Cash Flow¥ 23.40B¥ 8.21B¥ 2.54B¥ 22.13B¥ 12.01B
Investing Cash Flow¥ -31.29B¥ -40.39B¥ -30.28B¥ -59.73B¥ -9.10B
Financing Cash Flow¥ 21.57B¥ 35.41B¥ 17.48B¥ 46.54B¥ 184.00M
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History

Towa Pharmaceutical Co Debt to Assets

Towa Pharmaceutical Co Cash Flow

Towa Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis